Guillermo Quetell, MD
Plastic Surgery · East Syracuse, NYNPI 1790779825
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.3%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by AbbVie at 51.2% of the total. Reporting peaked in 2024 at $3,945 and has fallen 59.7% since, to $1,590 in 2025.
Across 124 payments — averaging $96.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Stryker$2K
- Mentor Worldwide LLC$2K
- TELA Bio, Inc.$1K
- Axogen$319
- Musculoskeletal Transplant Foundation Inc.$280
- plus $995 from 17 others
What the payments were for
- Travel & lodging$3,13026%
- Food & beverage$6,74656%
- Education$530%
- Gifts$2,05417%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $6,130 |
| Stryker | 5 | $1,729 |
| Mentor Worldwide LLC | 23 | $1,529 |
| TELA Bio, Inc. | 14 | $1,001 |
| Axogen | 6 | $319 |
| Musculoskeletal Transplant Foundation Inc. | 8 | $280 |
| Motiva USA, LLC | 2 | $171 |
| Pacira Pharmaceuticals Incorporated | 3 | $142 |
| Smith+Nephew | 3 | $123 |
| Medtronic | 4 | $112 |
| Sientra, Inc. | 2 | $71 |
| Endo Pharmaceuticals Inc. | 4 | $65 |
| Endo USA, Inc. | 2 | $54 |
| Integra Lifesciences Corporation | 2 | $48 |
| Solventum Corporation | 1 | $32 |
| KCI USA, Inc. | 1 | $30 |
| Davol Inc. | 1 | $29 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Tepha Inc | 1 | $25 |
| Mimedx Group, Inc. | 1 | $20 |
| Merz North America, Inc. | 1 | $19 |
| Coopersurgical, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE SALINE-FILLED BREAST IMPLANTS$5,498
- STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS$2,518
- REVOLVE$2,518
- NATRELLE$2,054
- SPY-PHI SYSTEM$1,615
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$731
- MENTOR MemoryGel Resterilizable Gel Sizer$701
- ARTOURA Breast Tissue Expander$585
- ALLODERM$235
- Motiva Implant Matrix$116
- ARTIA$114
- MemoryGel Breast Implants$112
- MemoryShape Breast Implants$112
- EXPAREL$106
How this compares
$11,983 in reported general payments places this provider in the 85th percentile of 363 plastic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 17 | $276 |
| Cephalexin | 13 | $49 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in East Syracuse
- Anthony DeboniEast Syracuse$17K
- Sachin ShridharaniNew York$1.1M
- Scot GlasbergNew York$959K
- Nolan KarpNew York$900K
- Michael LacquaBrooklyn$865K
- Sydney ColemanNew York$729K
- David RapaportNew York$578K
- Richard SwiftNew York$487K
- Michael KaneNew York$250K
- Z LorencNew York$225K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.